Cart
sales@molnova.com
Cintirorgon
CAS No. 2055536-64-4
Cintirorgon( LYC-55716 )
Catalog No. M23919 CAS No. 2055536-64-4
Cintirorgon is a selective, oral agonist of RORγ. Cintirorgon modulates gene expression of RORγ expressing T lymphocyte immune cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 187 | In Stock |
|
| 5MG | 143 | In Stock |
|
| 10MG | 197 | In Stock |
|
| 25MG | 330 | In Stock |
|
| 50MG | 479 | In Stock |
|
| 100MG | 695 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCintirorgon
-
NoteResearch use only, not for human use.
-
Brief DescriptionCintirorgon is a selective, oral agonist of RORγ. Cintirorgon modulates gene expression of RORγ expressing T lymphocyte immune cells.
-
DescriptionCintirorgon is a selective, oral agonist of RORγ. Cintirorgon modulates gene expression of RORγ expressing T lymphocyte immune cells.
-
In Vitro——
-
In Vivo——
-
SynonymsLYC-55716
-
PathwayCell Cycle/DNA Damage
-
TargetROCK
-
RecptorRORγ
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2055536-64-4
-
Formula Weight603.53
-
Molecular FormulaC27H23F6NO6S
-
Purity>98% (HPLC)
-
SolubilityDMSO:110 mg/mL (182.26 mM)
-
SMILESCC(C)(C[C@H]1CN(C2=C(O1)C=CC(=C2)C3=CC(=CC(=C3)F)OC(F)F)S(=O)(=O)C4=CC=CC(=C4)C(F)(F)F)C(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lycera Announces Initiation of Phase 1/2a Study ARGON of Immuno-Oncology Candidate LYC-55716 in Patients with Advanced Solid Tumors. Jan 04, 2017.
molnova catalog
related products
-
Azaindole 1
Azaindole 1 is a selective and ATP-competitive ROCK inhibitor with IC50 of 0.6 and 1.1?nM for human ROCK-1 and ROCK-2.
-
Y27632
Y-27632 is a selective ROCK1 (p160ROCK) inhibitor with Ki of 140 nM in a cell-free assay.
-
Narciclasine
Narciclasine, a natural product, modulates the Rho/Rho-kinase/LIM kinase/cofilin signaling pathway, greatly increasing GTPase RhoA activity.
